DK1161522T3 - Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider - Google Patents
Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptiderInfo
- Publication number
- DK1161522T3 DK1161522T3 DK00916131T DK00916131T DK1161522T3 DK 1161522 T3 DK1161522 T3 DK 1161522T3 DK 00916131 T DK00916131 T DK 00916131T DK 00916131 T DK00916131 T DK 00916131T DK 1161522 T3 DK1161522 T3 DK 1161522T3
- Authority
- DK
- Denmark
- Prior art keywords
- cells
- isolating
- polypeptides
- antibodies
- related hybridoma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70517—CD8
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12425399P | 1999-03-12 | 1999-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1161522T3 true DK1161522T3 (da) | 2006-12-04 |
Family
ID=22413749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00916131T DK1161522T3 (da) | 1999-03-12 | 2000-03-08 | Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1161522B1 (da) |
| JP (1) | JP4712194B2 (da) |
| AT (1) | ATE334192T1 (da) |
| AU (1) | AU3728400A (da) |
| CA (1) | CA2365639C (da) |
| DE (1) | DE60029570T2 (da) |
| DK (1) | DK1161522T3 (da) |
| WO (1) | WO2000055305A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001274931B2 (en) * | 2000-05-23 | 2006-03-30 | Nexell Therapeutics, Inc. | Reagents for cell selection and methods of use |
| EP3665201A4 (en) | 2017-08-09 | 2021-06-02 | Orionis Biosciences, Inc. | CD8 BINDERS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5006459A (en) * | 1986-03-31 | 1991-04-09 | T Cell Sciences, Inc. | Therapeutic and diagnostic methods using soluble T cell surface molecules |
| US5645837A (en) * | 1995-01-17 | 1997-07-08 | Thomas Jefferson University | Peptides that inhibit T cell activation and methods of using the same |
| US6001962A (en) * | 1996-11-15 | 1999-12-14 | The Regents Of The University Of California | Modified Fas ligands |
| WO1999054345A1 (en) * | 1998-04-21 | 1999-10-28 | Thomas Jefferson University | Cd8 antagonists |
-
2000
- 2000-03-08 AU AU37284/00A patent/AU3728400A/en not_active Abandoned
- 2000-03-08 CA CA2365639A patent/CA2365639C/en not_active Expired - Fee Related
- 2000-03-08 EP EP00916131A patent/EP1161522B1/en not_active Expired - Lifetime
- 2000-03-08 AT AT00916131T patent/ATE334192T1/de active
- 2000-03-08 JP JP2000605723A patent/JP4712194B2/ja not_active Expired - Fee Related
- 2000-03-08 WO PCT/US2000/005898 patent/WO2000055305A1/en not_active Ceased
- 2000-03-08 DE DE60029570T patent/DE60029570T2/de not_active Expired - Lifetime
- 2000-03-08 DK DK00916131T patent/DK1161522T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| JP4712194B2 (ja) | 2011-06-29 |
| EP1161522A1 (en) | 2001-12-12 |
| JP2003526332A (ja) | 2003-09-09 |
| DE60029570D1 (de) | 2006-09-07 |
| WO2000055305A1 (en) | 2000-09-21 |
| ATE334192T1 (de) | 2006-08-15 |
| AU3728400A (en) | 2000-10-04 |
| EP1161522B1 (en) | 2006-07-26 |
| DE60029570T2 (de) | 2007-08-16 |
| CA2365639C (en) | 2013-05-14 |
| CA2365639A1 (en) | 2000-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0765478T3 (da) | Positiv og positiv/negativ celleselektion medieret af peptidfrigørelse | |
| EP2336187B8 (en) | Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations | |
| PT1308507E (pt) | Anticorpo monoclonal anti-núcleo de hcv | |
| DK1232392T3 (da) | Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring | |
| AUPP525198A0 (en) | Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof | |
| EP0603307A4 (en) | MONOCLONAL ANTIBODIES TO PUTATIVE HCV-E2 / NS1 PROTEINS AND METHOD FOR USING THEM. | |
| DE60044977D1 (de) | Cocktail von nukleaseinhibitoren | |
| IS2508B (is) | Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir | |
| IL148113A0 (en) | Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof | |
| ATE279443T1 (de) | A3c6e2, ein monoklonaler antikörper spezifisch für den humanen stammzellfaktor (scf)-rezeptor | |
| DK0717850T3 (da) | Assaykit | |
| DK0709455T3 (da) | Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an | |
| MX2008000282A (es) | Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa. | |
| AU2003283240A1 (en) | Antibody for isolating and/or identifying mesenchymal stem cells and method for isolating and/or identifying mesenchymal stem cells | |
| DK1161522T3 (da) | Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider | |
| DK1386160T3 (da) | Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse | |
| SE0002835D0 (sv) | Method and kit for production of monoclonal antibodies | |
| DK1539817T3 (da) | Immunoassays til specifik bestemmelse af SCCA-isoformer | |
| DK0599913T3 (da) | Monoklonale antistoffer mod formodet hepatitis C-virus NS5-proteiner og anvendelsesmetoder af samme | |
| BR0204612A (pt) | Anticorpos monoclonais antinúcleo de hcv | |
| AU2007202851B2 (en) | Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations | |
| AR037216A1 (es) | Anticuerpos monoclonales antinucleares de hcv |